Itziar Casado
Impact in
- Modeling and Simulation top 5%
- COVID-19 epidemiological studies
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
- Epidemiology 31
- Influenza Virus Research Studies 25
- Respiratory viral infections research 16
- Pneumonia and Respiratory Infections 5
-
- SARS-CoV-2 and COVID-19 Research 6
- COVID-19 Clinical Research Studies 3
- Co-authors
- Jesús Castilla (42 shared papers)Iván Martínez‐Baz (37 shared papers)Carmen Ezpeleta (35 shared papers)Ana Navascués (30 shared papers)Camino Trobajo‐Sanmartín (17 shared papers)Marcela Guevara (14 shared papers)Cristina Burgui (13 shared papers)Ana Miqueleiz (10 shared papers)
- Journals
- Eurosurveillance (11 papers)The Journal of Infectious Diseases (3 papers)Vaccines (3 papers)Canadian Medical Association Journal (2 papers)Vaccine (2 papers)
- Partner nations
- SpainUnited StatesMongolia
In The Last Decade
Itziar Casado
47 papers receiving 739 citations
Itziar Casado's Hit Papers
Peers
Comparison fields: 5 of 63
- Modeling and Simulation 69
- Infectious Diseases 234
- Epidemiology 395
- Health 97
- Hepatology 55
Countries citing papers authored by Itziar Casado
This map shows the geographic impact of Itziar Casado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Itziar Casado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Itziar Casado more than expected).
Fields of papers citing papers by Itziar Casado
This network shows the impact of papers produced by Itziar Casado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Itziar Casado. The network helps show where Itziar Casado may publish in the future.
Co-authors
The 25 scholars most cited alongside Itziar Casado, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 56 | |
| 2 | 2021 | 51 | |
| 3 | Effectiveness of Nirsevimab Immunoprophylaxis Administered at Birth to Prevent Infant Hospitalisation for Respiratory Syncytial Virus Infection: A Population-Based Cohort Study Hit paper breakdown → | 2024 | 50 |
| 4 | 2021 | 49 | |
| 5 | 2016 | 37 | |
| 6 | 2018 | 34 | |
| 7 | 2017 | 34 | |
| 8 | 2016 | 29 | |
| 9 | 2022 | 25 | |
| 10 | 2018 | 25 | |
| 11 | 2017 | 23 | |
| 12 | 2018 | 23 | |
| 13 | 2012 | 20 | |
| 14 | 2015 | 19 | |
| 15 | 2016 | 18 | |
| 16 | 2023 | 17 | |
| 17 | 2022 | 15 | |
| 18 | 2017 | 15 | |
| 19 | 2014 | 15 | |
| 20 | 2022 | 14 |
About Itziar Casado
Itziar Casado is a scholar working on Epidemiology, Infectious Diseases, Modeling and Simulation, Health and Hepatology, having authored 49 papers that have together received 749 indexed citations. Recurring topics across this work include Influenza Virus Research Studies (25 papers), Respiratory viral infections research (16 papers), COVID-19 epidemiological studies (7 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Vaccine Coverage and Hesitancy (6 papers), Pneumonia and Respiratory Infections (5 papers), Hepatitis C virus research (5 papers) and COVID-19 Clinical Research Studies (3 papers). The work is most often cited by research in Modeling and Simulation (69 citations), Infectious Diseases (234 citations), Epidemiology (395 citations), Health (97 citations) and Hepatology (55 citations). Itziar Casado has collaborated with scholars based in Spain, United States and Mongolia. Frequent co-authors include Jesús Castilla, Iván Martínez‐Baz, Carmen Ezpeleta, Ana Navascués, Camino Trobajo‐Sanmartín, Marcela Guevara, Cristina Burgui, Ana Miqueleiz, Aitziber Aguinaga and Francisco Pozo. Their work appears in journals such as Eurosurveillance, The Journal of Infectious Diseases, Vaccines, Canadian Medical Association Journal and Vaccine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.